User: Guest  Login
Less Searchfields
Simple search
Title:

Transcatheter or Surgical Treatment of Aortic-Valve Stenosis.

Document type:
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Equivalence Trial; Comparative Study
Author(s):
Blankenberg, Stefan; Seiffert, Moritz; Vonthein, Reinhard; Baumgartner, Helmut; Bleiziffer, Sabine; Borger, Michael A; Choi, Yeong-Hoon; Clemmensen, Peter; Cremer, Jochen; Czerny, Martin; Diercks, Nina; Eitel, Ingo; Ensminger, Stephan; Frank, Derk; Frey, Norbert; Hagendorff, Andreas; Hagl, Christian; Hamm, Christian; Kappert, Utz; Karck, Matthias; Kim, Won-Keun; König, Inke R; Krane, Markus; Landmesser, Ulf; Linke, Axel; Maier, Lars S; Massberg, Steffen; Neumann, Franz-Josef; Reichenspurner, Her...     »
Abstract:
BACKGROUND: Among low-risk patients with severe, symptomatic aortic stenosis who are eligible for both transcatheter aortic-valve implantation (TAVI) and surgical aortic-valve replacement (SAVR), data are lacking on the appropriate treatment strategy in routine clinical practice. METHODS: In this randomized noninferiority trial conducted at 38 sites in Germany, we assigned patients with severe aortic stenosis who were at low or intermediate surgical risk to undergo either TAVI or SAVR. Percutaneous- and surgical-valve prostheses were selected according to operator discretion. The primary outcome was a composite of death from any cause or fatal or nonfatal stroke at 1 year. RESULTS: A total of 1414 patients underwent randomization (701 to the TAVI group and 713 to the SAVR group). The mean (±SD) age of the patients was 74±4 years; 57% were men, and the median Society of Thoracic Surgeons risk score was 1.8% (low surgical risk). The Kaplan-Meier estimate of the primary outcome at 1 year was 5.4% in the TAVI group and 10.0% in the SAVR group (hazard ratio for death or stroke, 0.53; 95% confidence interval [CI], 0.35 to 0.79; P<0.001 for noninferiority). The incidence of death from any cause was 2.6% in the TAVI group and 6.2% in the SAVR group (hazard ratio, 0.43; 95% CI, 0.24 to 0.73); the incidence of stroke was 2.9% and 4.7%, respectively (hazard ratio, 0.61; 95% CI, 0.35 to 1.06). Procedural complications occurred in 1.5% and 1.0% of patients in the TAVI and SAVR groups, respectively. CONCLUSIONS: Among patients with severe aortic stenosis at low or intermediate surgical risk, TAVI was noninferior to SAVR with respect to death from any cause or stroke at 1 year. (Funded by the German Center for Cardiovascular Research and the German Heart Foundation; DEDICATE-DZHK6 ClinicalTrials.gov number, NCT03112980.).
Journal title abbreviation:
N Engl J Med
Year:
2024
Journal volume:
390
Journal issue:
17
Pages contribution:
1572-1583
Fulltext / DOI:
doi:10.1056/NEJMoa2400685
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/38588025
Print-ISSN:
0028-4793
TUM Institution:
Klinik für Herz- und Gefäßchirurgie (DHM) (Prof. Krane)
 BibTeX